Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 947

1.

CCR4 is rarely expressed in CCR4-mutated T/NK-cell lymphomas other than adult T-cell leukemia/lymphoma.

Sakamoto Y, Fujii K, Murase S, Nakano S, Masaki A, Murase T, Kusumoto S, Iida S, Utsunomiya A, Ueda R, Ishida T, Inagaki H.

Int J Hematol. 2019 Aug 29. doi: 10.1007/s12185-019-02728-5. [Epub ahead of print]

PMID:
31468320
2.

Serum lipidomics for exploring biomarkers of bortezomib therapy in patients with multiple myeloma.

Maekawa K, Ri M, Nakajima M, Sekine A, Ueda R, Tohkin M, Miyata N, Saito Y, Iida S.

Cancer Sci. 2019 Aug 23. doi: 10.1111/cas.14178. [Epub ahead of print]

3.

Increased infiltration of CCR4-positive regulatory T cells in prostate cancer tissue is associated with a poor prognosis.

Watanabe M, Kanao K, Suzuki S, Muramatsu H, Morinaga S, Kajikawa K, Kobayashi I, Nishikawa G, Kato Y, Zennami K, Nakamura K, Tsuzuki T, Yoshikawa K, Ueda R, Sumitomo M.

Prostate. 2019 Oct;79(14):1658-1665. doi: 10.1002/pros.23890. Epub 2019 Aug 7.

PMID:
31390096
4.

Intravoxel incoherent motion perfusion in patients with Moyamoya disease: comparison with 15O-gas positron emission tomography.

Hara S, Hori M, Ueda R, Hagiwara A, Hayashi S, Inaji M, Tanaka Y, Maehara T, Ishii K, Aoki S, Nariai T.

Acta Radiol Open. 2019 May 23;8(5):2058460119846587. doi: 10.1177/2058460119846587. eCollection 2019 May.

5.

Genomic backgrounds of Japanese patients with undiagnosed neurodevelopmental disorders.

Yamamoto T, Imaizumi T, Yamamoto-Shimojima K, Lu Y, Yanagishita T, Shimada S, Chong PF, Kira R, Ueda R, Ishiyama A, Takeshita E, Momosaki K, Ozasa S, Akiyama T, Kobayashi K, Oomatsu H, Kitahara H, Yamaguchi T, Imai K, Kurahashi H, Okumura A, Oguni H, Seto T, Okamoto N.

Brain Dev. 2019 Oct;41(9):776-782. doi: 10.1016/j.braindev.2019.05.007. Epub 2019 Jun 4.

PMID:
31171384
6.

White matter changes follow low-frequency repetitive transcranial magnetic stimulation plus intensive occupational therapy for motor paralysis after stroke: a DTI study using TBSS.

Ueda R, Yamada N, Abo M, Senoo A.

Acta Neurol Belg. 2019 May 21. doi: 10.1007/s13760-019-01150-2. [Epub ahead of print]

PMID:
31115787
7.

Ventricular volumetry and free-water corrected diffusion tensor imaging of the anterior thalamic radiation in idiopathic normal pressure hydrocephalus.

Saito A, Kamagata K, Ueda R, Nakazawa M, Andica C, Irie R, Nakajima M, Miyajima M, Hori M, Tanaka F, Arai H, Aoki S.

J Neuroradiol. 2019 Apr 26. pii: S0150-9861(18)30195-0. doi: 10.1016/j.neurad.2019.04.003. [Epub ahead of print]

PMID:
31034894
8.

Local Administration of GITR Agonistic Antibody Induces a Stronger Antitumor Immunity than Systemic Delivery.

Narumi K, Miyakawa R, Shibasaki C, Henmi M, Mizoguchi Y, Ueda R, Hashimoto H, Hiraoka N, Yoshida T, Aoki K.

Sci Rep. 2019 Apr 3;9(1):5562. doi: 10.1038/s41598-019-41724-x.

9.

CCR4 Expression in Tumor-Infiltrating Regulatory T Cells in Patients with Squamous Cell Carcinoma of the Lung: A Prognostic Factor for Relapse and Survival.

Asai N, Kubo A, Suzuki S, Murotani K, Numanami H, Yoshikawa K, Ueda R, Yamaguchi E.

Cancer Invest. 2019;37(3):163-173. doi: 10.1080/07357907.2019.1582848. Epub 2019 Mar 25.

PMID:
30907146
11.

A Pilot Study of Vaccine Therapy with Multiple Glioma Oncoantigen/Glioma Angiogenesis-Associated Antigen Peptides for Patients with Recurrent/Progressive High-Grade Glioma.

Kikuchi R, Ueda R, Saito K, Shibao S, Nagashima H, Tamura R, Morimoto Y, Sasaki H, Noji S, Kawakami Y, Yoshida K, Toda M.

J Clin Med. 2019 Feb 20;8(2). pii: E263. doi: 10.3390/jcm8020263.

12.

Estimation of Gadolinium-based Contrast Agent Concentration Using Quantitative Synthetic MRI and Its Application to Brain Metastases: A Feasibility Study.

Fujita S, Nakazawa M, Hagiwara A, Ueda R, Horita M, Maekawa T, Irie R, Andica C, Kunishima Kumamaru K, Hori M, Aoki S.

Magn Reson Med Sci. 2019 Feb 19. doi: 10.2463/mrms.mp.2018-0119. [Epub ahead of print]

13.

[Acute myeloid leukemia with sudden onset bilateral lower extremity paralysis caused by disseminated mucormycosis following unrelated bone marrow transplantation].

Itakusu K, Inoue T, Abe M, Ueda R, Sakurai A, Miyazaki Y, Nakase K, Yoshida I, Nawa Y.

Rinsho Ketsueki. 2019;60(1):17-21. doi: 10.11406/rinketsu.60.17. Japanese.

PMID:
30726818
14.

Unraveling Specific Brain Microstructural Damage in Moyamoya Disease Using Diffusion Magnetic Resonance Imaging and Positron Emission Tomography.

Hara S, Hori M, Ueda R, Hayashi S, Inaji M, Tanaka Y, Maehara T, Ishii K, Aoki S, Nariai T.

J Stroke Cerebrovasc Dis. 2019 Apr;28(4):1113-1125. doi: 10.1016/j.jstrokecerebrovasdis.2018.12.038. Epub 2019 Jan 21.

PMID:
30679013
15.

EBV-positive mucocutaneous ulcer arising in rheumatoid arthritis patients treated with methotrexate: Single center series of nine cases.

Satou A, Banno S, Hanamura I, Takahashi E, Takahara T, Nobata H, Katsuno T, Takami A, Ito Y, Ueda R, Nakamura S, Tsuzuki T.

Pathol Int. 2019 Jan;69(1):21-28. doi: 10.1111/pin.12745. Epub 2019 Jan 7.

PMID:
30615240
16.

Establishment and characterization of a novel vincristine-resistant diffuse large B-cell lymphoma cell line containing the 8q24 homogeneously staining region.

Mizuno S, Hanamura I, Ota A, Karnan S, Kanasugi J, Nakamura A, Takasugi S, Uchino K, Horio T, Goto M, Murakami S, Gotou M, Yamamoto H, Watarai M, Shikami M, Hosokawa Y, Miwa H, Taniwaki M, Ueda R, Nitta M, Takami A.

FEBS Open Bio. 2018 Nov 20;8(12):1977-1991. doi: 10.1002/2211-5463.12538. eCollection 2018 Dec.

17.

The Body-wide Transcriptome Landscape of Disease Models.

Kozawa S, Ueda R, Urayama K, Sagawa F, Endo S, Shiizaki K, Kurosu H, Maria de Almeida G, Hasan SM, Nakazato K, Ozaki S, Yamashita Y, Kuro-O M, Sato TN.

iScience. 2018 Apr 27;2:238-268. doi: 10.1016/j.isci.2018.03.014. Epub 2018 Mar 29.

18.

Correlation analysis of motor function improvement and brain structure for upper limb paralysis.

Ueda R, Yamada N, Abo M, Senoo A.

Neuroreport. 2019 Jan 16;30(2):77-81. doi: 10.1097/WNR.0000000000001160.

PMID:
30399028
19.

Microstructural Damage in Normal-Appearing Brain Parenchyma and Neurocognitive Dysfunction in Adult Moyamoya Disease.

Hara S, Hori M, Murata S, Ueda R, Tanaka Y, Inaji M, Maehara T, Aoki S, Nariai T.

Stroke. 2018 Oct;49(10):2504-2507. doi: 10.1161/STROKEAHA.118.022367.

PMID:
30355113
20.

Vertebrobasilar Dolichoectasia Causing Symptomatic Hydrocephalus Due to Third Ventricular Compression.

Oishi Y, Ueda R, Kuranari Y, Imanishi T.

J Stroke Cerebrovasc Dis. 2018 Dec;27(12):3503-3504. doi: 10.1016/j.jstrokecerebrovasdis.2018.08.021. Epub 2018 Sep 23.

PMID:
30257790
21.

Generation of PTEN‑knockout (‑/‑) murine prostate cancer cells using the CRISPR/Cas9 system and comprehensive gene expression profiling.

Takao A, Yoshikawa K, Karnan S, Ota A, Uemura H, De Velasco MA, Kura Y, Suzuki S, Ueda R, Nishino T, Hosokawa Y.

Oncol Rep. 2018 Nov;40(5):2455-2466. doi: 10.3892/or.2018.6683. Epub 2018 Sep 5.

PMID:
30226608
22.

GITR Agonism Enhances Cellular Metabolism to Support CD8+ T-cell Proliferation and Effector Cytokine Production in a Mouse Tumor Model.

Sabharwal SS, Rosen DB, Grein J, Tedesco D, Joyce-Shaikh B, Ueda R, Semana M, Bauer M, Bang K, Stevenson C, Cua DJ, Zúñiga LA.

Cancer Immunol Res. 2018 Oct;6(10):1199-1211. doi: 10.1158/2326-6066.CIR-17-0632. Epub 2018 Aug 28.

PMID:
30154083
23.

Increased Tim-3+ T cells in PBMCs during nivolumab therapy correlate with responses and prognosis of advanced esophageal squamous cell carcinoma patients.

Kato R, Yamasaki M, Urakawa S, Nishida K, Makino T, Morimoto-Okazawa A, Kawashima A, Iwahori K, Suzuki S, Ueda R, Mori M, Satoh T, Doki Y, Wada H.

Cancer Immunol Immunother. 2018 Nov;67(11):1673-1683. doi: 10.1007/s00262-018-2225-x. Epub 2018 Aug 20.

PMID:
30128737
24.

A Rare Case of Thyrotropin-Secreting Pituitary Adenoma Coexisting with Papillary Thyroid Carcinoma Presenting with Visual Disturbance without Hyperthyroidism.

Inoue H, Shinojima N, Ueda R, Yamamoto K, Ishii N, Igata M, Kawashima J, Araki E, Iwase H, Mikami Y, Yano S, Mukasa A.

World Neurosurg. 2018 Nov;119:394-399. doi: 10.1016/j.wneu.2018.07.274. Epub 2018 Aug 7.

PMID:
30096503
25.

Cyclin-dependent kinase 9 as a potential specific molecular target in NK-cell leukemia/lymphoma.

Kinoshita S, Ishida T, Ito A, Narita T, Masaki A, Suzuki S, Yoshida T, Ri M, Kusumoto S, Komatsu H, Shimizu N, Inagaki H, Kuroda T, Scholz A, Ueda R, Sanda T, Iida S.

Haematologica. 2018 Dec;103(12):2059-2068. doi: 10.3324/haematol.2018.191395. Epub 2018 Aug 3.

26.

Correction to: Multicenter phase 1/2 study of forodesine in patients with relapsed peripheral T cell lymphoma.

Maruyama D, Tsukasaki K, Uchida T, Maeda Y, Shibayama H, Nagai H, Kurosawa M, Suehiro Y, Hatake K, Ando K, Yoshida I, Hidaka M, Murayama T, Okitsu Y, Tsukamoto N, Taniwaki M, Suzumiya J, Tamura K, Yamauchi T, Ueda R, Tobinai K.

Ann Hematol. 2018 Dec;97(12):2529-2530. doi: 10.1007/s00277-018-3455-x.

PMID:
30054705
27.

Myelin Measurement: Comparison Between Simultaneous Tissue Relaxometry, Magnetization Transfer Saturation Index, and T1w/T2w Ratio Methods.

Hagiwara A, Hori M, Kamagata K, Warntjes M, Matsuyoshi D, Nakazawa M, Ueda R, Andica C, Koshino S, Maekawa T, Irie R, Takamura T, Kumamaru KK, Abe O, Aoki S.

Sci Rep. 2018 Jul 12;8(1):10554. doi: 10.1038/s41598-018-28852-6.

28.

Multicenter phase 1/2 study of forodesine in patients with relapsed peripheral T cell lymphoma.

Maruyama D, Tsukasaki K, Uchida T, Maeda Y, Shibayama H, Nagai H, Kurosawa M, Suehiro Y, Hatake K, Ando K, Yoshida I, Hidaka M, Murayama T, Okitsu Y, Tsukamoto N, Taniwaki M, Suzumiya J, Tamura K, Yamauchi T, Ueda R, Tobinai K.

Ann Hematol. 2019 Jan;98(1):131-142. doi: 10.1007/s00277-018-3418-2. Epub 2018 Jul 5. Erratum in: Ann Hematol. 2018 Dec;97(12):2529-2530.

29.

CCR4 mutations associated with superior outcome of adult T-cell leukemia/lymphoma under mogamulizumab treatment.

Sakamoto Y, Ishida T, Masaki A, Murase T, Yonekura K, Tashiro Y, Tokunaga M, Utsunomiya A, Ito A, Kusumoto S, Iida S, Ueda R, Inagaki H.

Blood. 2018 Aug 16;132(7):758-761. doi: 10.1182/blood-2018-02-835991. Epub 2018 Jun 21. No abstract available.

30.

Current state of therapeutic development for rare cancers in Japan, and proposals for improvement.

Kawai A, Goto T, Shibata T, Tani K, Mizutani S, Nishikawa A, Shibata T, Matsumoto S, Nagata K, Narukawa M, Matsui S, Ando M, Toguchida J, Monden M, Heike T, Kimura S, Ueda R.

Cancer Sci. 2018 May;109(5):1731-1737. doi: 10.1111/cas.13568.

31.

Human T-cell lymphotropic/leukemia virus type 1 (HTLV-1) Tax-specific T-cell exhaustion in HTLV-1-infected individuals.

Masaki A, Ishida T, Suzuki S, Ito A, Narita T, Kinoshita S, Ri M, Kusumoto S, Komatsu H, Inagaki H, Ueda R, Iida S.

Cancer Sci. 2018 Aug;109(8):2383-2390. doi: 10.1111/cas.13654. Epub 2018 Jun 27.

32.

Seizure imitators monitored using video-EEG in children with intellectual disabilities.

Ueda R, Shimizu-Motohashi Y, Sugai K, Takeshita E, Ishiyama A, Saito T, Komaki H, Nakagawa E, Sasaki M.

Epilepsy Behav. 2018 Jul;84:122-126. doi: 10.1016/j.yebeh.2018.05.006. Epub 2018 May 20.

PMID:
29791879
33.

A pilot study of peptide vaccines for VEGF receptor 1 and 2 in patients with recurrent/progressive high grade glioma.

Shibao S, Ueda R, Saito K, Kikuchi R, Nagashima H, Kojima A, Kagami H, Pareira ES, Sasaki H, Noji S, Kawakami Y, Yoshida K, Toda M.

Oncotarget. 2018 Apr 20;9(30):21569-21579. doi: 10.18632/oncotarget.25131. eCollection 2018 Apr 20.

34.

Diffusion Tensor Imaging Evaluation of Neural Network Development in Patients Undergoing Therapeutic Repetitive Transcranial Magnetic Stimulation following Stroke.

Yamada N, Ueda R, Kakuda W, Momosaki R, Kondo T, Hada T, Sasaki N, Hara T, Senoo A, Abo M.

Neural Plast. 2018 Mar 13;2018:3901016. doi: 10.1155/2018/3901016. eCollection 2018.

35.

Application of Quantitative Microstructural MR Imaging with Atlas-based Analysis for the Spinal Cord in Cervical Spondylotic Myelopathy.

Hori M, Hagiwara A, Fukunaga I, Ueda R, Kamiya K, Suzuki Y, Liu W, Murata K, Takamura T, Hamasaki N, Irie R, Kamagata K, Kumamaru KK, Suzuki M, Aoki S.

Sci Rep. 2018 Mar 26;8(1):5213. doi: 10.1038/s41598-018-23527-8.

36.

Neurite orientation dispersion and density imaging of the nigrostriatal pathway in Parkinson's disease: Retrograde degeneration observed by tract-profile analysis.

Andica C, Kamagata K, Hatano T, Okuzumi A, Saito A, Nakazawa M, Ueda R, Motoi Y, Kamiya K, Suzuki M, Hori M, Kumamaru KK, Hattori N, Aoki S.

Parkinsonism Relat Disord. 2018 Jun;51:55-60. doi: 10.1016/j.parkreldis.2018.02.046. Epub 2018 Feb 28.

37.

Nasal diphtheria (chronic carriage) caused by nontoxigenic Corynebacterium diphtheriae.

Okamoto K, Hatakeyama S, Sugita C, Ogura K, Ueda R, Kouda H, Nakata J.

J Infect Chemother. 2018 Sep;24(9):759-762. doi: 10.1016/j.jiac.2018.01.015. Epub 2018 Feb 24.

PMID:
29487033
38.

[Valve-sparing Replacement in Patients with Aortic Root Dilatation].

Yamazaki K, Minatoya K, Ueda R, Takehara M, Sakamoto K, Ide Y, Kanemitsu H, Ueyama K, Ikeda T.

Kyobu Geka. 2018 Jan;71(1):19-24. Japanese.

PMID:
29483476
39.

Follow-up of a randomised phase II study of chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: impact on allogeneic haematopoietic stem cell transplantation.

Ishida T, Jo T, Takemoto S, Suzushima H, Suehiro Y, Choi I, Yoshimitsu M, Saburi Y, Nosaka K, Utsunomiya A, Kobayashi Y, Yamamoto K, Fujiwara H, Ishitsuka K, Yoshida S, Taira N, Imada K, Kato K, Moriuchi Y, Yoshimura K, Takahashi T, Tobinai K, Ueda R.

Br J Haematol. 2019 Feb;184(3):479-483. doi: 10.1111/bjh.15123. Epub 2018 Feb 7. No abstract available.

PMID:
29411857
40.

Executive control and faithfulness: only long-term romantic relationships require prefrontal control.

Ueda R, Yanagisawa K, Ashida H, Abe N.

Exp Brain Res. 2018 Mar;236(3):821-828. doi: 10.1007/s00221-018-5181-y. Epub 2018 Jan 17.

PMID:
29344686
41.

Interactions of Propofol With Human Voltage-gated Kv1.5 Channel Determined by Docking Simulation and Mutagenesis Analyses.

Kojima A, Fukushima Y, Ito Y, Ding WG, Ueda R, Seto T, Kitagawa H, Matsuura H.

J Cardiovasc Pharmacol. 2018 Jan;71(1):10-18. doi: 10.1097/FJC.0000000000000538.

PMID:
29283926
42.

Characterization of two carbonyl reductases from Ogataea polymorpha NBRC 0799.

Isobe K, Miki S, Ueda R, Shichida S, Matsui D, Oku Y, Asano Y.

Appl Microbiol Biotechnol. 2018 Feb;102(3):1307-1316. doi: 10.1007/s00253-017-8668-8. Epub 2017 Dec 13.

PMID:
29238872
43.

The Relationship between Neurite Density Measured with Confocal Microscopy in a Cleared Mouse Brain and Metrics Obtained from Diffusion Tensor and Diffusion Kurtosis Imaging.

Irie R, Kamagata K, Kerever A, Ueda R, Yokosawa S, Otake Y, Ochi H, Yoshizawa H, Hayashi A, Tagawa K, Okazawa H, Takahashi K, Sato K, Hori M, Arikawa-Hirasawa E, Aoki S.

Magn Reson Med Sci. 2018 Apr 10;17(2):138-144. doi: 10.2463/mrms.mp.2017-0031. Epub 2017 Dec 7.

44.

Clinical significance of tryptophan catabolism in Hodgkin lymphoma.

Masaki A, Ishida T, Maeda Y, Ito A, Suzuki S, Narita T, Kinoshita S, Takino H, Yoshida T, Ri M, Kusumoto S, Komatsu H, Inagaki H, Ueda R, Choi I, Suehiro Y, Iida S.

Cancer Sci. 2018 Jan;109(1):74-83. doi: 10.1111/cas.13432. Epub 2017 Nov 29.

45.

Adoptive immunotherapy combined with FP treatment for head and neck cancer: An in vitro study.

Nishio-Nagai M, Suzuki S, Yoshikawa K, Ueda R, Kazaoka Y.

Int J Oncol. 2017 Nov;51(5):1471-1481. doi: 10.3892/ijo.2017.4142. Epub 2017 Oct 2.

46.

Implicit attitudes and executive control interact to regulate interest in extra-pair relationships.

Ueda R, Yanagisawa K, Ashida H, Abe N.

Cogn Affect Behav Neurosci. 2017 Dec;17(6):1210-1220. doi: 10.3758/s13415-017-0543-7.

PMID:
29039129
47.

Enhancer profiling identifies critical cancer genes and characterizes cell identity in adult T-cell leukemia.

Wong RWJ, Ngoc PCT, Leong WZ, Yam AWY, Zhang T, Asamitsu K, Iida S, Okamoto T, Ueda R, Gray NS, Ishida T, Sanda T.

Blood. 2017 Nov 23;130(21):2326-2338. doi: 10.1182/blood-2017-06-792184. Epub 2017 Oct 4.

48.

Mogamulizumab for relapsed adult T-cell leukemia-lymphoma: Updated follow-up analysis of phase I and II studies.

Ishida T, Utsunomiya A, Jo T, Yamamoto K, Kato K, Yoshida S, Takemoto S, Suzushima H, Kobayashi Y, Imaizumi Y, Yoshimura K, Kawamura K, Takahashi T, Tobinai K, Ueda R.

Cancer Sci. 2017 Oct;108(10):2022-2029. doi: 10.1111/cas.13343. Epub 2017 Aug 28.

49.

Analysis of White Matter Damage in Patients with Multiple Sclerosis via a Novel In Vivo MR Method for Measuring Myelin, Axons, and G-Ratio.

Hagiwara A, Hori M, Yokoyama K, Nakazawa M, Ueda R, Horita M, Andica C, Abe O, Aoki S.

AJNR Am J Neuroradiol. 2017 Oct;38(10):1934-1940. doi: 10.3174/ajnr.A5312. Epub 2017 Aug 3.

50.

Phase I/II study of pralatrexate in Japanese patients with relapsed or refractory peripheral T-cell lymphoma.

Maruyama D, Nagai H, Maeda Y, Nakane T, Shimoyama T, Nakazato T, Sakai R, Ishikawa T, Izutsu K, Ueda R, Tobinai K.

Cancer Sci. 2017 Oct;108(10):2061-2068. doi: 10.1111/cas.13340. Epub 2017 Sep 4.

Supplemental Content

Support Center